» Articles » PMID: 37518364

HEATR3 Involved in the Cell Proliferation, Metastasis and Cell Cycle Development of Bladder Cancer Acts As a Tumor Suppressor

Overview
Specialty Genetics
Date 2023 Jul 30
PMID 37518364
Authors
Affiliations
Soon will be listed here.
Abstract

The study was designed to detect the expression and clinical significance of the HEATR3 gene in bladder cancer (BCa) and to preliminarily explore whether this gene can affect the occurrence and development of BCa through the AKT/ERK signaling pathway. The expression and prognostic value of HEATR3 were explored based on The Cancer Genome Atlas (TCGA) and Genotypic Tissue Expression (GTEx) databases. Microarray immunohistochemical analysis was performed in 30 BCa cases to investigate the level of HEATR3 protein and to explore the relationship between HEATR3 and the clinicopathological features of BCa. Western Blot and qRT-PCR were used to detect HEATR3 protein and mRNA in BCa cell lines (5637, TCCSUP, SW780) and fallopian tube epithelial cell (SV-HUC-1). CCK8 method was employed to study the proliferation of BCa cells after heat treatment. Transwell assay was conducted to analyze the effect of HEATR3 on cell migration and invasion. And cell cycle and apoptosis were detected by flow cytometry. Furthermore, Western Blot assay was used to probe the effects of down-regulation of HEATR3 expression on the expression and phosphorylation levels of AKT and ERK proteins in BCa cells. Bioinformatics analysis showed that HEATR3 was significantly up-regulated in BCa, and high HEATR3 expression was associated with poor prognosis of BCa patients. In vitro experiments demonstrated that HEATR3 expression was up-regulated in BCa tissues compared with that in adjacent tissues. HEATR3 protein was also up-regulated in malignant cell lines. HEATR3 knockdown in BCa cells could inhibit cell proliferation, invasion and migration, block cell cycle and promote cell apoptosis. At the same time, HEATR3 knockdowns reduced the expression levels of p-AKT and p-ERK proteins. HEATR3 knockdown inhibits the development of BCa cells through the AKT/ERK signaling pathway. and it may become one of the most promising molecular targets for BCa treatment.

Citing Articles

Genome-wide meta-analysis identifies novel risk loci for uterine fibroids within and across multiple ancestry groups.

Kim J, Williams A, Noh H, Jasper E, Jones S, Jaworski J Nat Commun. 2025; 16(1):2273.

PMID: 40050615 PMC: 11885530. DOI: 10.1038/s41467-025-57483-5.


Identification of Brain Cell Type-Specific Therapeutic Targets for Glioma From Genetics.

Gui J, Chen J, Wan K, Liu Y, Huang K, Zhu X CNS Neurosci Ther. 2024; 30(12):e70185.

PMID: 39722126 PMC: 11669572. DOI: 10.1111/cns.70185.

References
1.
Cai J, Huang S, Yi Y, Bao S . Downregulation of PTPN18 can inhibit proliferation and metastasis and promote apoptosis of endometrial cancer. Clin Exp Pharmacol Physiol. 2019; 46(8):734-742. DOI: 10.1111/1440-1681.13098. View

2.
Calvino F, Kharde S, Ori A, Hendricks A, Wild K, Kressler D . Symportin 1 chaperones 5S RNP assembly during ribosome biogenesis by occupying an essential rRNA-binding site. Nat Commun. 2015; 6:6510. PMC: 4396368. DOI: 10.1038/ncomms7510. View

3.
Chen E, Yang F, He H, Li Q, Zhang W, Xing J . Alteration of tumor suppressor BMP5 in sporadic colorectal cancer: a genomic and transcriptomic profiling based study. Mol Cancer. 2018; 17(1):176. PMC: 6302470. DOI: 10.1186/s12943-018-0925-7. View

4.
Chung C, Kanetsky P, Wang Z, Hildebrandt M, Koster R, Skotheim R . Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet. 2013; 45(6):680-5. PMC: 3723930. DOI: 10.1038/ng.2634. View

5.
Jia X, Liu P, Zhang M, Feng T, Tang H, Tang Z . Genetic variants at 6p21, 10q23, 16q21 and 22q12 are associated with esophageal cancer risk in a Chinese Han population. Int J Clin Exp Med. 2016; 8(10):19381-7. PMC: 4694479. View